What are the appropriate doses per kilogram per day of bilastine and montelukast for a 2‑year‑old boy weighing 10 kg, and what is the correct cough syrup dosage for this child?

Dosing for Bilastine and Montelukast in a 2-Year-Old, 10 kg Child

For this 2-year-old child weighing 10 kg, montelukast 4 mg once daily is the appropriate dose, while bilastine is NOT approved or recommended for children under 6 years of age.

Montelukast Dosing

The correct dose is 4 mg once daily for children aged 2-5 years 1, 2. This applies regardless of the child's weight within this age range. The FDA-approved formulation for this age group is the 4-mg chewable tablet or 4-mg oral granules 1, 2.

Key Points for Montelukast:

• Dose calculation: This is NOT weight-based in this age group—it's a fixed 4 mg daily dose 2, 3
• Per kg calculation: For this 10 kg child, this equals 0.4 mg/kg/day
• Timing: Administer once daily, typically in the evening 2
• Formulation options: Either chewable tablet or oral granules can be used 1, 2

The 4 mg dose was selected through population pharmacokinetic studies demonstrating that it achieves similar systemic exposure (AUC) in 2-5 year-olds as the 10 mg adult dose 3.

Critical Safety Warning:

The FDA issued a Boxed Warning for montelukast in March 2020 regarding neuropsychiatric adverse events 4. Before prescribing:

• Counsel parents about potential behavioral changes, mood disturbances, or suicidal thoughts
• Ensure the benefits outweigh risks for this individual child
• Consider alternative therapies, particularly inhaled corticosteroids for asthma 1

Bilastine Dosing

Bilastine is NOT approved for children under 6 years of age. While recent research has evaluated bilastine 10 mg in children aged 2-5 years 5, this represents investigational use only. The study showed:

• 10 mg once daily was well-tolerated in 2-5 year-olds
• Peak concentrations occurred 1 hour post-dose
• Good safety profile with minimal adverse events

However, this remains off-label use and should not be prescribed routinely until regulatory approval is obtained. For a 10 kg child in this age group, there is no established approved dose.

Alternative Antihistamine Options:

For allergic conditions in this age group, consider FDA-approved alternatives such as:

• Cetirizine (approved for ≥6 months)
• Loratadine (approved for ≥2 years)

Cough Syrup Dosing

The question about "cough syrup dosage" cannot be answered without specifying which medication. Cough is not a primary indication for either bilastine or montelukast.

Important Considerations:

• Cough suppressants are generally NOT recommended for children under 4-6 years due to limited efficacy and safety concerns
• If cough is due to asthma, treat the underlying asthma with appropriate controller therapy (inhaled corticosteroids preferred) 1
• If cough is due to viral upper respiratory infection, supportive care is typically sufficient 6
• Avoid combination products containing bilastine/dextromethorphan/phenylephrine in this age group—these are studied only in adults and adolescents 7

Clinical Algorithm for This Child:

1. Identify the underlying condition:

   • Asthma → Inhaled corticosteroids are preferred first-line; montelukast is alternative 1
   • Allergic rhinitis → Intranasal corticosteroids preferred; montelukast is alternative
   • Urticaria → Use approved antihistamines (not bilastine in this age)

2. If prescribing montelukast:

   • Obtain informed consent regarding neuropsychiatric risks
   • Prescribe 4 mg once daily (chewable tablet or granules)
   • Schedule follow-up in 4-6 weeks to assess response 1
   • Discontinue if no clear benefit after 4-6 weeks 1

3. Monitor for:

   • Behavioral changes, sleep disturbances, mood alterations
   • Treatment efficacy at 4-6 weeks
   • Consider step-down if well-controlled for ≥3 months 1

Do not use bilastine in this 2-year-old child—it lacks regulatory approval for this age group.